NCT06372340

Brief Summary

The aim of this study is to propose an intelligent diagnosis and treatment system for for pelvic floor dysfunction in elderly women. The main question it aims to answer: 1) How can the investigators find out early if older women have different pelvic floor muscle functions? 2)How can the investigators give personalized treatment plans based on differences in pelvic floor function? Participants will be assigned different training programs by the system. The investigators will compare the treatment effects and costs of older women with pelvic floor dysfunction using and not using the system. All the participants will be offered examinations for pelvic floor function and different treatments. All examinations and treatments are non-invasive.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 18, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

April 30, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

July 3, 2024

Status Verified

January 1, 2024

Enrollment Period

1.3 years

First QC Date

April 10, 2024

Last Update Submit

June 30, 2024

Conditions

Keywords

Urinary incontinencePelvic floor muscleIntelligent diagnosis and treatment systemElderly femalePelvic floor dysfunction

Outcome Measures

Primary Outcomes (2)

  • Modified Oxford Scale (MOS)

    The modified Oxford scale(Mos) is presently the gold standard used to assess pelvic floor muscle strength. Digital assessment of pelvic floor muscle contraction will be performed by the examiner inserting the index and middle fingers approximately 4 cm into the vagina (only the index finger in the case of very narrow hiatus) and palpating the puborectalis muscle at each side of the vagina during contraction. The Modified Oxford Scale (MOS) was used to rate pelvic floor muscle contraction on a scale of 0-5: 0 = no contraction; 1 = minor muscle 'flicker'; 2 = weak muscle contraction; 3 = moderate muscle contraction; 4 = good muscle contraction and 5 = strong muscle contraction.

    Baseline, Month 3, Month 6, Month 12

  • Surface Electromyography Data

    Pelvic floor muscle(PFM) surface electromyography (EMG) testing is one method for assessing the quantity and quality of PFM function. The electromyograms regarding the contraction and relaxation capacity of the PFM will be recorded simultaneously from electrode probes on perineum and adjacent muscles.

    Baseline, Month 3, Month 6, Month 12

Secondary Outcomes (3)

  • The score of Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF)

    Baseline, Month 3, Month 6, Month 12

  • The score of the Pelvic Floor Distress Inventory (PFDI-20)

    Baseline, Month 3, Month 6, Month 12

  • Subjective staging used Pelvic Organ Prolapse Quantification (POP-Q) System

    Baseline, Month 3, Month 6, Month 12

Study Arms (2)

Supervised and individualized pelvic floor muscle training

EXPERIMENTAL

Subjects in the experimental group (EG) will accept individualized pelvic floor muscle training under the introduction of skilled clinicians.

Procedure: Personalized pelvic floor rehabilitation program generated by the intelligent diagnosis and treatment system.

Standard training program

ACTIVE COMPARATOR

Subjects in the control group(CG) will accept pelvic floor muscle training according to the handbook or oral guidance

Procedure: Standard pelvic floor muscle training(PFMT) program

Interventions

Utilizing machine learning to process and analyze vast amounts of previously collected data, the investigators will establish an intelligent system that can generate personalized pelvic floor exercise prescription by matching factors such as general clinical information and pelvic floor muscle strength data. The experimental group will receive tailored program, including pelvic floor muscle training with diverse intensity and frequency, electrical stimulation, magnetic stimulation, biofeedback and other treatments. The results will ultimately be compared with those taking standardized pelvic floor muscle training only.

Supervised and individualized pelvic floor muscle training

Participants will be given handbooks with detailed training program: the basic regimen consists of 3 sets of 8 to 12 contractions sustained for 8 to 10 sec each, performed 3 times a day. Patients should try to do this every day and continue for at least 15 to 20 weeks.

Standard training program

Eligibility Criteria

Age60 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Women over 60 years old.

You may not qualify if:

  • Severe pelvic organ prolapse (POP-Q stage\>III)
  • History of pelvic floor surgery
  • Malignant tumor in pelvic
  • Allergic to nickel
  • Acute inflammation of pelvic or genital tract
  • Subjects who has cognitive impairment and cannot sign an informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Hospital

Beijing, Beijing Municipality, 100005, China

RECRUITING

MeSH Terms

Conditions

Pelvic Organ ProlapseUrinary IncontinenceDisease

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathologic Processes

Study Officials

  • Mi Li, Ph.D.

    Beijing Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Assessments regarding pelvic floor muscle strength will be conducted by an assessor blind to treatment allocation. The assessor will go through a profound assessment training program. Due to the nature of the intervention neither participants nor care providers can be blinded to allocation, but are strongly inculcated not to disclose the allocation status of the participant at the follow up assessments. An employee outside the research team will feed data into the computer in separate datasets so that the researchers can analyse data without having access to information about the allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The participants will be allocated to experimental group(EG) or the control group(CG). Subjects in the experimental group (EG) will receive personalized pelvic floor muscle training guidance provided by the system, whereas subjects in the control group(CG) will exercise according to the handbook or oral guidance.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2024

First Posted

April 18, 2024

Study Start

April 30, 2024

Primary Completion

August 31, 2025

Study Completion

December 31, 2025

Last Updated

July 3, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

Data obtained through this study may be provided to qualified researchers with academic interest in pelvic floor muscle dysfunction. Data or samples shared will be coded, with no protected health information (PHI) included. Approval of the request and execution of all applicable agreements (i.e. a material transfer agreement) are prerequisites to the sharing of data with the requesting party.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Data requests can be submitted starting 12 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis.
Access Criteria
Access to trial individual participant data (IPD) can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). For more information or to submit a request, please contact mindy99999@126.com.

Locations